L Capital Partners Mergers and Acquisitions Summary

Private Equity Firm Profile

L Capital Partners’ most common sectors for investment arelife science (25%) and medical products (25%) . The Firm’s most common investment types include venture (88%) and growth capital (7%). In total, L Capital Partners has invested in 10 US states and 2 different countries. Its largest (disclosed) acquisition occurred in 2007 when it acquired Locus Pharmaceuticals for $30M.

The Firm’s most common exit type is trade sale (72%). L Capital Partners’ largest (disclosed) exit occurred in 2008 when it sold Protez Pharmaceuticals for $400M.

Subscribe to Mergr to view L Capital Partners’ full profile and discover more small private equity firm investors just like it.

M&A Summary

  • M&A Total Activity23
    • M&A Buy Activity16
    • M&A Sell Activity7
  • Total Sectors Invested 10
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 12
  • M&A Advisors 1

L Capital Partners

10 East 53rd Street, 37th Floor,
New York, New York 10022
United States
(212) 675-7755
www.lcapitalpartners.com
info@lcapitalpartners.com

L Capital Partners is a specialist private equity firm focused on investing in companies operating within the healthcare, technology, and energy/environmental sectors, looking to bring 'groundbreaking products to market'. Within healthcare, L Capital looks to invest in biopharmaceutical and medical device businesses. Within technology, the Firm's emphasis is on security/defense and IT businesses. And within the energy/environmental sector, the L Capital's focus is investing in opportunities that 'improve the quality of life'. L Capital was formed in 2004 and has offices in New York City and Tel Aviv, Israel.


Investment Criteria

Sectors of Interest: Aerospace, Communications, Defense, Electronics, Energy Services and Equipment, Environmental, Healthcare Services, Information Technology, Life Science, Medical Products, Oil/Gas Exploration, Renewable Energy, Semiconductors, Technology Hardware

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital, Stake Purchase, Venture

Geographic Preferences: East US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '20 '21 '22 '23 '24 '25 T
Buy (0.0/yr) # 16 - - - - - 16
vol $58M $58M
Sell (0.0/yr) # 7 - - - - - 7
vol $445M $445M
  23

Most Recent M&A

Company Date Value Type
WiSpry, Inc. 2015-05-11 - Trade Sale
Irvine, California · www.wispry.com
Vicini SpA 2014-04-07 - Growth Capital
San Mauro Pascoli, · www.vicinishoes.com
iScience Interventional, Inc. 2014-01-06 - Trade Sale
Menlo Park, California · www.iscienceinterventional.com
OnPATH Technologies, Inc. 2012-11-01 40M USD Trade Sale
Marlton, New Jersey · www.onpathtech.com
Eleme Medical, Inc. 2011-02-03 5M USD Trade Sale
Merrimack, New Hampshire · www.smoothshapes.com
Tengion, Inc. 2010-04-09 - IPO
Winston-Salem, North Carolina · www.tengion.com
iScience Interventional, Inc. 2009-05-01 21M USD Venture
Menlo Park, California · www.iscienceinterventional.com
WiSpry, Inc. 2009-03-01 - Venture
Irvine, California · www.wispry.com
Evogen, Inc. 2008-12-12 3M USD Venture
Kansas City, Missouri · www.evogen.com
CeNeRx BioPharma, Inc. 2008-10-17 - Venture
Cary, North Carolina · www.cenerx.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 1 (17%) 30M (81%) 4 (25%) 30M (52%)
Medical Products - - 4 (25%) 21M (36%)
Information Technology 1 (17%) 4M (11%) 1 (6%) 4M (7%)
Technology Hardware 1 (17%) 3M (8%) 1 (6%) 3M (5%)
Aerospace - - 1 (6%) -
Communications - - 1 (6%) -
Consumer Products 1 (17%) - 1 (6%) -
Electronics 1 (17%) - 1 (6%) -
Environmental 1 (17%) - 1 (6%) -
Semiconductors - - 1 (6%) -
Total 6 $37M 16 $58M

Acquisitions By Geo

State/Country Current # Value All-time # Value
United States 5 (100%) 37M (100%) 15 (100%) 58M (100%)
  California - - 3 (20%) 21M (36%)
  Pennsylvania 1 (20%) 30M (81%) 2 (13%) 30M (52%)
  New York 1 (20%) 4M (11%) 2 (13%) 4M (7%)
  North Carolina - - 2 (13%) -
  Missouri 1 (20%) 3M (8%) 1 (7%) 3M (5%)
  Wisconsin 1 (20%) - 1 (7%) -
  Maryland 1 (20%) - 1 (7%) -
  Virginia - - 1 (7%) -
  New Jersey - - 1 (7%) -
  New Hampshire - - 1 (7%) -
Total 5 $37M 15 $58M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Venture 5 (83%) 37M (100%) 14 (88%) 58M (100%)
Growth Capital 1 (17%) - 1 (6%) -
Stake Purchase - - 1 (6%) -
Total 6 $37M 16 $58M

Exits by Deal Type

Type Total # Value
Trade Sale - Public Company 5 (71%) 445M (100%)
Bankruptcy 1 (14%) -
IPO 1 (14%) -
Total 7 $445M

Top M&A Advisors

Financial Deals
DVR Capital
1

Deal Values

buy # Total
< $100M 4 $58M
TOTAL $58M
Largest Locus Pharmaceuticals, Inc.
$30M (2007-02-13)
sell # Total
$100M to $1B 1 $400M
< $100M 2 $45M
TOTAL $445M
Largest Protez Pharmaceuticals, Inc.
$400M (2008-06-04)

M&A Connections

Deals
Exited to
Strategic(s)
71%
5 (71%)

FAQ

When was L Capital Partners founded?

L Capital Partners was founded in 2004.

What type of investor is L Capital Partners?

L Capital Partners is a private equity firm.

Where is L Capital Partners headquartered?

L Capital Partners is headquartered in New York, New York.

How much capital does L Capital Partners have under management?

L Capital Partners has 165M USD under management.

 Subscribe to unlock this and 215,016
investor and company profiles

Sign-up today to get full access

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.7K Private Equity Firms
  • 208K M&A Transactions
  • 210K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.7K M&A Advisors
    (Investment Banks and Law Firms)
  • 81K M&A Contacts
    (PE and M&A Advisors)

What next?

Get Full Access

Full access to Mergr's investor, acquirer, and transaction data starts here.